Cargando…
Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
Autores principales: | Barbhaiya, Medha, Levine, Jonah M., Siegel, Caroline H., Bykerk, Vivian P., Jannat-Khah, Deanna, Mandl, Lisa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556788/ https://www.ncbi.nlm.nih.gov/pubmed/34716843 http://dx.doi.org/10.1007/s10067-021-05963-6 |
Ejemplares similares
-
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City
por: Barbhaiya, Medha, et al.
Publicado: (2022) -
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022) -
Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology
por: Stamm, Bessie, et al.
Publicado: (2022) -
Rheumatic Disease-Related Symptoms During the Height of the COVID-19 Pandemic
por: Mancuso, Carol A., et al.
Publicado: (2020) -
Flares in patients with systemic lupus erythematosus
por: McElhone, Kathleen, et al.
Publicado: (2020)